1982
DOI: 10.1016/0014-2999(82)90515-5
|View full text |Cite
|
Sign up to set email alerts
|

Opiate receptor binding of nicomorphine and its hydrolysis products in rat brain

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1991
1991
2008
2008

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 11 publications
(2 citation statements)
references
References 7 publications
0
2
0
Order By: Relevance
“…[7][8][9][10][11][12] In the present study, the morphine 3-esters, when compared with the parent compound, were up to 4600-, 300-, and 9300-fold less potent for binding to µ-, δ-, and κ-opioid receptors, respectively ( Table 4). [7][8][9][10][11][12] In the present study, the morphine 3-esters, when compared with the parent compound, were up to 4600-, 300-, and 9300-fold less potent for binding to µ-, δ-, and κ-opioid receptors, respectively ( Table 4).…”
Section: Resultsmentioning
confidence: 50%
“…[7][8][9][10][11][12] In the present study, the morphine 3-esters, when compared with the parent compound, were up to 4600-, 300-, and 9300-fold less potent for binding to µ-, δ-, and κ-opioid receptors, respectively ( Table 4). [7][8][9][10][11][12] In the present study, the morphine 3-esters, when compared with the parent compound, were up to 4600-, 300-, and 9300-fold less potent for binding to µ-, δ-, and κ-opioid receptors, respectively ( Table 4).…”
Section: Resultsmentioning
confidence: 50%
“…Nicomorphine (Vilan | is the 3,6-dinicotinoyl ester of morphine, which can be considered as a morphinomimetic prodrug that is approximately equipotent to morphine [1]. However, its onset is quicker, its duration of action longer, and it shows fewer side-effects than morphine.…”
Section: Introductionmentioning
confidence: 99%